AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-100 >>
Results: 26-50/100
RECEPTOR DIMERIZATION IS NOT A FACTOR IN THE SIGNALING ACTIVITY OF A TRANSFORMING VARIANT EPIDERMAL GROWTH-FACTOR RECEPTOR (EGFRVIII)
Authors: CHU CT EVERISS KD WIKSTRAND CJ BATRA SK KUNG HJ BIGNER DD
Citation: Ct. Chu et al., RECEPTOR DIMERIZATION IS NOT A FACTOR IN THE SIGNALING ACTIVITY OF A TRANSFORMING VARIANT EPIDERMAL GROWTH-FACTOR RECEPTOR (EGFRVIII), Biochemical journal, 324, 1997, pp. 855-861
MONOCLONAL-ANTIBODIES TO GROWTH-FACTORS AND GROWTH-FACTOR RECEPTORS -THEIR DIAGNOSTIC AND THERAPEUTIC POTENTIAL IN BRAIN-TUMORS
Authors: ASHLEY DM BATRA SK BIGNER DD
Citation: Dm. Ashley et al., MONOCLONAL-ANTIBODIES TO GROWTH-FACTORS AND GROWTH-FACTOR RECEPTORS -THEIR DIAGNOSTIC AND THERAPEUTIC POTENTIAL IN BRAIN-TUMORS, Journal of neuro-oncology, 35(3), 1997, pp. 259-273
A GENETICALLY-MODIFIED ALLOGENEIC CELLULAR VACCINE GENERATES MHC CLASS I-RESTRICTED CYTOTOXIC RESPONSES AGAINST TUMOR-ASSOCIATED ANTIGENS AND PROTECTS AGAINST CNS TUMORS IN-VIVO
Authors: ASHLEY DM SAMPSON JH ARCHER GE BATRA SK BIGNER DD HALE LP
Citation: Dm. Ashley et al., A GENETICALLY-MODIFIED ALLOGENEIC CELLULAR VACCINE GENERATES MHC CLASS I-RESTRICTED CYTOTOXIC RESPONSES AGAINST TUMOR-ASSOCIATED ANTIGENS AND PROTECTS AGAINST CNS TUMORS IN-VIVO, Journal of neuroimmunology, 78(1-2), 1997, pp. 34-46
A METHOD FOR LABELING INTERNALIZING ANTIBODIES WITH ASTATINE-211
Authors: REIST CJ FOULON CF BIGNER DD ZALUTSKY MR
Citation: Cj. Reist et al., A METHOD FOR LABELING INTERNALIZING ANTIBODIES WITH ASTATINE-211, The Journal of nuclear medicine, 38(5), 1997, pp. 15-15
DOSIMETRY METHODS FOR PATIENTS WITH MALIGNANT CNS TUMORS TREATED WITHI-131 81C6 VIA SURGICALLY CREATED CYSTIC RESECTION CAVITY
Authors: AKABANI G THORSTAD WL BROWN MT COLEMAN RE ZALUTSKY MR BIGNER DD
Citation: G. Akabani et al., DOSIMETRY METHODS FOR PATIENTS WITH MALIGNANT CNS TUMORS TREATED WITHI-131 81C6 VIA SURGICALLY CREATED CYSTIC RESECTION CAVITY, The Journal of nuclear medicine, 38(5), 1997, pp. 395-395
CHARACTERIZATION OF SPONTANEOUS MURINE ASTROCYTOMA AND ABROGATION OF ITS TUMORIGENICITY BY CYTOKINE SECRETION
Authors: SAMPSON JH ASHLEY DM ARCHER GE FUCHS HE DRANOFF G HALE LP BIGNER DD
Citation: Jh. Sampson et al., CHARACTERIZATION OF SPONTANEOUS MURINE ASTROCYTOMA AND ABROGATION OF ITS TUMORIGENICITY BY CYTOKINE SECRETION, Neurosurgery, 41(6), 1997, pp. 1365-1372
INTRAVENTRICULAR IMMUNOTOXIN THERAPY FOR LEPTOMENINGEAL NEOPLASIA - COMMENT
Authors: BIGNER DD SAMPSON JH
Citation: Dd. Bigner et Jh. Sampson, INTRAVENTRICULAR IMMUNOTOXIN THERAPY FOR LEPTOMENINGEAL NEOPLASIA - COMMENT, Neurosurgery, 41(5), 1997, pp. 1050-1051
BONE MARROW-GENERATED DENDRITIC CELLS PULSED WITH TUMOR EXTRACTS OR TUMOR RNA INDUCE ANTITUMOR IMMUNITY AGAINST CENTRAL-NERVOUS-SYSTEM TUMORS
Authors: ASHLEY DM FAIOLA B NAIR S HALE LP BIGNER DD GILBOA E
Citation: Dm. Ashley et al., BONE MARROW-GENERATED DENDRITIC CELLS PULSED WITH TUMOR EXTRACTS OR TUMOR RNA INDUCE ANTITUMOR IMMUNITY AGAINST CENTRAL-NERVOUS-SYSTEM TUMORS, The Journal of experimental medicine, 186(7), 1997, pp. 1177-1182
IMPROVED TARGETING OF AN ANTIEPIDERMAL GROWTH-FACTOR RECEPTOR VARIANT-III MONOCLONAL-ANTIBODY IN TUMOR XENOGRAFTS AFTER LABELING USING N-SUCCINIMIDYL 5-IODO-3-PYRIDINECARBOXYLATE
Authors: REIST CJ ARCHER GE WIKSTRAND CJ BIGNER DD ZALUTSKY MR
Citation: Cj. Reist et al., IMPROVED TARGETING OF AN ANTIEPIDERMAL GROWTH-FACTOR RECEPTOR VARIANT-III MONOCLONAL-ANTIBODY IN TUMOR XENOGRAFTS AFTER LABELING USING N-SUCCINIMIDYL 5-IODO-3-PYRIDINECARBOXYLATE, Cancer research, 57(8), 1997, pp. 1510-1515
PTEN GENE-MUTATIONS ARE SEEN IN HIGH-GRADE BUT NOT IN LOW-GRADE GLIOMAS
Authors: RASHEED BKA STENZEL TT MCLENDON RE PARSONS R FRIEDMAN AH FRIEDMAN HS BIGNER DD BIGNER SH
Citation: Bka. Rasheed et al., PTEN GENE-MUTATIONS ARE SEEN IN HIGH-GRADE BUT NOT IN LOW-GRADE GLIOMAS, Cancer research, 57(19), 1997, pp. 4187-4190
CELL-SURFACE LOCALIZATION AND DENSITY OF THE TUMOR-ASSOCIATED VARIANTOF THE EPIDERMAL GROWTH-FACTOR RECEPTOR, EGFRVIII
Authors: WIKSTRAND CJ MCLENDON RE FRIEDMAN AH BIGNER DD
Citation: Cj. Wikstrand et al., CELL-SURFACE LOCALIZATION AND DENSITY OF THE TUMOR-ASSOCIATED VARIANTOF THE EPIDERMAL GROWTH-FACTOR RECEPTOR, EGFRVIII, Cancer research, 57(18), 1997, pp. 4130-4140
METHYLATOR RESISTANCE MEDIATED BY MISMATCH REPAIR DEFICIENCY IN A GLIOBLASTOMA-MULTIFORME XENOGRAFT
Authors: FRIEDMAN HS JOHNSON SP DONG Q SCHOLD SC RASHEED BKA BIGNER SH ALIOSMAN F DOLAN E COLVIN OM HOUGHTON P GERMAIN G DRUMMOND JT KEIR S MARCELLI S BIGNER DD MODRICH P
Citation: Hs. Friedman et al., METHYLATOR RESISTANCE MEDIATED BY MISMATCH REPAIR DEFICIENCY IN A GLIOBLASTOMA-MULTIFORME XENOGRAFT, Cancer research, 57(14), 1997, pp. 2933-2936
INTRATHECAL I-131-LABELED ANTITENASCIN MONOCLONAL-ANTIBODY 81C6 TREATMENT OF PATIENTS WITH LEPTOMENINGEAL NEOPLASMS OR PRIMARY BRAIN-TUMOR RESECTION CAVITIES WITH SUBARACHNOID COMMUNICATION - PHASE-I TRIAL RESULTS
Authors: BROWN MT COLEMAN RE FRIEDMAN AH FRIEDMAN HS MCLENDON RE REIMAN R FELSBERG GJ TIEN RD BIGNER SH ZALUTSKY MR ZHAO XG WIKSTRAND CJ PEGRAM CN HERNDON JE VICK NA PALEOLOGOS N FREDERICKS RK SCHOLD SC BIGNER DD
Citation: Mt. Brown et al., INTRATHECAL I-131-LABELED ANTITENASCIN MONOCLONAL-ANTIBODY 81C6 TREATMENT OF PATIENTS WITH LEPTOMENINGEAL NEOPLASMS OR PRIMARY BRAIN-TUMOR RESECTION CAVITIES WITH SUBARACHNOID COMMUNICATION - PHASE-I TRIAL RESULTS, Clinical cancer research, 2(6), 1996, pp. 963-972
CHIMERIC ANTI-TENASCIN ANTIBODY 81C6 - INCREASED TUMOR-LOCALIZATION COMPARED WITH ITS MURINE PARENT
Authors: ZALUTSKY MR ARCHER GE GARG PK BATRA SK BIGNER DD
Citation: Mr. Zalutsky et al., CHIMERIC ANTI-TENASCIN ANTIBODY 81C6 - INCREASED TUMOR-LOCALIZATION COMPARED WITH ITS MURINE PARENT, Nuclear medicine and biology, 23(4), 1996, pp. 449-458
RADIOTOXICITY OF SYSTEMICALLY ADMINISTERED [AT-211]ASTATIDE IN B6C3F1AND BALB C (NU/NU) MICE - A LONG-TERM SURVIVAL STUDY WITH HISTOLOGIC ANALYSIS/
Authors: MCLENDON RE ARCHER GE GARG PK BIGNER DD ZALUTSKY MR
Citation: Re. Mclendon et al., RADIOTOXICITY OF SYSTEMICALLY ADMINISTERED [AT-211]ASTATIDE IN B6C3F1AND BALB C (NU/NU) MICE - A LONG-TERM SURVIVAL STUDY WITH HISTOLOGIC ANALYSIS/, International journal of radiation oncology, biology, physics, 35(1), 1996, pp. 69-80
ENHANCEMENT OF MELPHALAN ACTIVITY BY INHIBITION OF DNA POLYMERASE-ALPHA AND DNA POLYMERASE-BETA
Authors: MOYNIHAN K ELION GB ALIOSMAN F MARCELLI S KEIR S BIGNER DD FRIEDMAN HS
Citation: K. Moynihan et al., ENHANCEMENT OF MELPHALAN ACTIVITY BY INHIBITION OF DNA POLYMERASE-ALPHA AND DNA POLYMERASE-BETA, Cancer chemotherapy and pharmacology, 38(4), 1996, pp. 349-354
REPAIR ANALYSIS OF 4-HYDROPEROXYCYCLOPHOSPHAMIDE-INDUCED DNA INTERSTRAND CROSS-LINKING IN THE C-MYC GENE IN 4-HYDROPEROXYCYCLOPHAMIDE-SENSITIVE AND 4-HYDROPEROXYCYCLOPHAMIDE-RESISTANT MEDULLOBLASTOMA CELL-LINES
Authors: DONG Q BULLOCK N ALIOSMAN F COLVIN OM BIGNER DD FRIEDMAN HS
Citation: Q. Dong et al., REPAIR ANALYSIS OF 4-HYDROPEROXYCYCLOPHOSPHAMIDE-INDUCED DNA INTERSTRAND CROSS-LINKING IN THE C-MYC GENE IN 4-HYDROPEROXYCYCLOPHAMIDE-SENSITIVE AND 4-HYDROPEROXYCYCLOPHAMIDE-RESISTANT MEDULLOBLASTOMA CELL-LINES, Cancer chemotherapy and pharmacology, 37(3), 1996, pp. 242-246
RADIOIMMUNOTHERAPY WITH ALPHA-PARTICLE EMITTING RADIOIMMUNOCONJUGATES
Authors: ZALUTSKY MR BIGNER DD
Citation: Mr. Zalutsky et Dd. Bigner, RADIOIMMUNOTHERAPY WITH ALPHA-PARTICLE EMITTING RADIOIMMUNOCONJUGATES, Acta oncologica, 35(3), 1996, pp. 373-379
IN-VIVO GROWTH-CONDITIONS SUPPRESS THE EXPRESSION OF GANGLIOSIDE GM2 AND FAVOR THAT OF LACTO SERIES GANGLIOSIDES IN THE HUMAN GLIOMA D-54MGCELL-LINE
Authors: FREDMAN P WIKSTRAND CJ MANSSON JE REIFENBERGER G BIGNER SH RASHEED A SVENNERHOLM L BIGNER DD
Citation: P. Fredman et al., IN-VIVO GROWTH-CONDITIONS SUPPRESS THE EXPRESSION OF GANGLIOSIDE GM2 AND FAVOR THAT OF LACTO SERIES GANGLIOSIDES IN THE HUMAN GLIOMA D-54MGCELL-LINE, Glycoconjugate journal, 13(3), 1996, pp. 391-399
PRIMARY BRAIN-TUMOR INCIDENCE RATES IN 4 UNITED-STATES REGIONS, 1985-1989 - A PILOT-STUDY
Authors: DAVIS FG MALINSKI N HAENSZEL W CHANG J FLANNERY J GERSHMAN S DIBBLE R BIGNER DD
Citation: Fg. Davis et al., PRIMARY BRAIN-TUMOR INCIDENCE RATES IN 4 UNITED-STATES REGIONS, 1985-1989 - A PILOT-STUDY, Neuroepidemiology, 15(2), 1996, pp. 103-112
A METHOD FOR THE RADIOHALOGENATION OF INTERNALIZING ANTIBODIES
Authors: REIST CJ GARG PK ALSTON KL BIGNER DD ZALUTSKY MR
Citation: Cj. Reist et al., A METHOD FOR THE RADIOHALOGENATION OF INTERNALIZING ANTIBODIES, The Journal of nuclear medicine, 37(10), 1996, pp. 1825-1825
SUCCESSFUL TREATMENT OF CHILDHOOD PILOCYTIC ASTROCYTOMAS METASTATIC TO THE LEPTOMENINGES WITH HIGH-DOSE CYCLOPHOSPHAMIDE
Authors: MCCOWAGE G TIEN R MCLENDON R FELSBERG G FUCHS H GRAHAM ML KURTZBERG J MOGHRABI A FERRELL L KERBY T DUNCANBROWN M STEWART E ROBERTSON PL COLVIN OM GOLEMBE B BIGNER DD FRIEDMAN HS
Citation: G. Mccowage et al., SUCCESSFUL TREATMENT OF CHILDHOOD PILOCYTIC ASTROCYTOMAS METASTATIC TO THE LEPTOMENINGES WITH HIGH-DOSE CYCLOPHOSPHAMIDE, Medical and pediatric oncology, 27(1), 1996, pp. 32-39
TREATMENT OF PATIENTS WITH PINEALOBLASTOMA WITH HIGH-DOSE CYCLOPHOSPHAMIDE
Authors: ASHLEY DM LONGEE D TIEN R FUCHS H GRAHAM ML KURTZBERG O CASEY J OLSON J MEIER L FERRELL L KERBY T DUNCANBROWN M STEWART E COLVIN OM PIPAS JM MCCOWAGE G MCLENDON R BIGNER DD FRIEDMAN HS
Citation: Dm. Ashley et al., TREATMENT OF PATIENTS WITH PINEALOBLASTOMA WITH HIGH-DOSE CYCLOPHOSPHAMIDE, Medical and pediatric oncology, 26(6), 1996, pp. 387-392
PHASE-I STUDIES OF RADIOLABELED I-131 81C6 ANTI-TENASCIN MONOCLONAL-ANTIBODY IN PATIENTS WITH RECURRENT CYSTIC GLIOMAS OR SURGICALLY CREATED BRAIN-TUMOR RESECTION CAVITIES - PRELIMINARY-RESULTS
Authors: BROWN MT COLEMAN RE FRIEDMAN AF FRIEDMAN HS PERRY JR MCLENDON RE BIGNER SH ZALUTSKY MR SCHOLD SC BIGNER DD
Citation: Mt. Brown et al., PHASE-I STUDIES OF RADIOLABELED I-131 81C6 ANTI-TENASCIN MONOCLONAL-ANTIBODY IN PATIENTS WITH RECURRENT CYSTIC GLIOMAS OR SURGICALLY CREATED BRAIN-TUMOR RESECTION CAVITIES - PRELIMINARY-RESULTS, Neurology, 46(2), 1996, pp. 66002-66002
RECOMBINANT IMMUNOTOXINS SPECIFIC FOR A MUTANT EPIDERMAL GROWTH-FACTOR RECEPTOR - TARGETING WITH A SINGLE-CHAIN ANTIBODY VARIABLE DOMAIN ISOLATED BY PHAGE DISPLAY
Authors: LORIMER IAJ KEPPLERHAFKEMEYER A BEERS RA PEGRAM CN BIGNER DD PASTAN I
Citation: Iaj. Lorimer et al., RECOMBINANT IMMUNOTOXINS SPECIFIC FOR A MUTANT EPIDERMAL GROWTH-FACTOR RECEPTOR - TARGETING WITH A SINGLE-CHAIN ANTIBODY VARIABLE DOMAIN ISOLATED BY PHAGE DISPLAY, Proceedings of the National Academy of Sciences of the United Statesof America, 93(25), 1996, pp. 14815-14820
Risultati: 1-25 | 26-50 | 51-75 | 76-100 >>